Zheng Xing Xing Ye Ri Bao·2025-11-13 08:44Core Insights - The biopharmaceutical sector experienced a rise of 1.06% on November 13, with BoHui Innovation leading the gains [1] - The Shanghai Composite Index closed at 4029.5, up 0.73%, while the Shenzhen Component Index closed at 13476.52, up 1.78% [1] Stock Performance - BoHui Innovation (300318) closed at 8.17, with a significant increase of 13.47% and a trading volume of 1.4092 million shares [1] - Other notable performers included: - Sanofi (688336) at 73.00, up 6.57% with a trading volume of 137,200 shares [1] - Jinke (688670) at 23.36, up 5.23% with a trading volume of 124,300 shares [1] - Rongchang Bio (688331) at 89.00, up 3.37% with a trading volume of 68,500 shares [1] Capital Flow - The biopharmaceutical sector saw a net outflow of 211 million yuan from institutional investors, while retail investors contributed a net inflow of 86.65 million yuan [2] - The capital flow for specific stocks included: - Sanofi (688336) with a net inflow of 35.23 million yuan from institutional investors [3] - Junshi Biosciences (688180) with a net inflow of 29.67 million yuan from institutional investors [3] - Long Spring High-tech (000661) experienced a net outflow of 59.78 million yuan from institutional investors [3]